{"nct_id":"NCT02538666","title":"An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy","status":"COMPLETED","status_verified_date":"2022-12","start_date":"2015-10-13","start_date_type":"ACTUAL","primary_completion_date":"2018-10-01","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}